Koch W - Search Results

1

Cytochrome P450 2C19 loss-of-function polymorphism and stent thrombosis following percutaneous coronary intervention.

Sibbing D, Stegherr J, Latz W, Koch W, Mehilli J, Dörrler K, Morath T, Schömig A, Kastrati A, von Beckerath N. Sibbing D, et al. Among authors: koch w. Eur Heart J. 2009 Apr;30(8):916-22. doi: 10.1093/eurheartj/ehp041. Epub 2009 Feb 4. Eur Heart J. 2009. PMID: 19193675

2

CD14 gene -159C/T polymorphism is not associated with coronary artery disease and myocardial infarction.

Koch W, Kastrati A, Mehilli J, von Beckerath N, Schömig A. Koch W, et al. Am Heart J. 2002 Jun;143(6):971-6. doi: 10.1067/mhj.2002.122512. Am Heart J. 2002. PMID: 12075251

3

Association of a genetic variant of endothelial nitric oxide synthase with the 1 year clinical outcome after coronary stent placement.

Gorchakova O, Koch W, von Beckerath N, Mehilli J, Schömig A, Kastrati A. Gorchakova O, et al. Among authors: koch w. Eur Heart J. 2003 May;24(9):820-7. doi: 10.1016/s0195-668x(02)00824-2. Eur Heart J. 2003. PMID: 12727149

4

4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and risk of restenosis after coronary artery stenting.

Böttiger C, Koch W, Lahn C, Mehilli J, von Beckerath N, Schömig A, Kastrati A. Böttiger C, et al. Among authors: koch w. Am Heart J. 2003 Nov;146(5):855-61. doi: 10.1016/S0002-8703(03)00363-6. Am Heart J. 2003. PMID: 14597935

5

The 5A/6A polymorphism of the stromelysin-1 gene and restenosis after percutaneous coronary interventions.

Hoppmann P, Koch W, Schömig A, Kastrati A. Hoppmann P, et al. Among authors: koch w. Eur Heart J. 2004 Feb;25(4):335-41. doi: 10.1016/j.ehj.2003.12.004. Eur Heart J. 2004. PMID: 14984923

6

Apolipoprotein E gene polymorphisms and thrombosis and restenosis after coronary artery stenting.

Koch W, Mehilli J, Pfeufer A, Schömig A, Kastrati A. Koch W, et al. J Lipid Res. 2004 Dec;45(12):2221-6. doi: 10.1194/jlr.M400148-JLR200. Epub 2004 Oct 1. J Lipid Res. 2004. PMID: 15466371 Free article.

7

Toll-like receptor 4 gene polymorphisms and myocardial infarction: no association in a Caucasian population.

Koch W, Hoppmann P, Pfeufer A, Schömig A, Kastrati A. Koch W, et al. Eur Heart J. 2006 Nov;27(21):2524-9. doi: 10.1093/eurheartj/ehl231. Epub 2006 Sep 5. Eur Heart J. 2006. PMID: 16954131

8

Heme oxygenase-1 gene promoter polymorphism and restenosis following coronary stenting.

Tiroch K, Koch W, von Beckerath N, Kastrati A, Schömig A. Tiroch K, et al. Among authors: koch w. Eur Heart J. 2007 Apr;28(8):968-73. doi: 10.1093/eurheartj/ehm036. Epub 2007 Mar 30. Eur Heart J. 2007. PMID: 17400606

9

Cytochrome 2C19*17 allelic variant, platelet aggregation, bleeding events, and stent thrombosis in clopidogrel-treated patients with coronary stent placement.

Sibbing D, Koch W, Gebhard D, Schuster T, Braun S, Stegherr J, Morath T, Schömig A, von Beckerath N, Kastrati A. Sibbing D, et al. Among authors: koch w. Circulation. 2010 Feb 2;121(4):512-8. doi: 10.1161/CIRCULATIONAHA.109.885194. Epub 2010 Jan 18. Circulation. 2010. PMID: 20083681

10

Protective effect of the CYP2C19 *17 polymorphism with increased activation of clopidogrel on cardiovascular events.

Tiroch KA, Sibbing D, Koch W, Roosen-Runge T, Mehilli J, Schömig A, Kastrati A. Tiroch KA, et al. Among authors: koch w. Am Heart J. 2010 Sep;160(3):506-12. doi: 10.1016/j.ahj.2010.06.039. Am Heart J. 2010. PMID: 20826260

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,614 results

Search Page

Filters